Bariatric Biobank of Manitoba, Canada

Registration Status: Completed

Objective: The Manitoba Bariatric Surgery Biobank will store blood, adipose tissue and skeletal muscle samples collected from patients during bariatric surgery. Biomarker profiles will be determined and compared to those of samples collected 1- and 2-years following surgery. One of our objectives is to evaluate the relationship of clinical and metabolic factors as well as adipokine and cytokine profiles on pre- and post- excess body weight loss (1-year and 2-year) and remission/relapse of bariatric surgery outcomes (Type 2 diabetes mellitus, hypertension, dyslipidemia, depression). Being able to determine a pattern in biomarker profiles that may predict diabetes recidivism or failure of excess weight loss following bariatric surgery will provide the opportunity to tailor healthcare delivery to individual needs. The breadth of the negative impacts of obesity, including increased morbidity and mortality, reduction in quality of life, and substantial health care expenditures provides the impetus to discover innovative, integrated, and effective clinical treatment strategies and to build infrastructure that supports collaborative multidisciplinary research. The Manitoba Bariatric Biobank will be a pivotal contribution to surgical research and is an innovative approach to facilitating collaborative research with significant disruptive potential.

Registered Biobank Name Bariatric Biobank of Manitoba
Biobank Leader Krista Hardy
Country Canada
Email for biobank inquiries khardy@sbgh.mb.ca
Principal Investigator Dr. Krista Hardy
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: